Agitation in Alzheimer's Disease

Sponsor
National Institute on Aging (NIA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000179
Collaborator
(none)
16

Study Details

Study Description

Brief Summary

Agitation affects 70 to 90 percent of patients with AD. Signs of agitation include verbal and physical aggressiveness, irritability, wandering, and restlessness. These behaviors often make caring for patients at home very difficult. Trazodone and haldol are two of the most commonly prescribed drugs for agitation in AD patients. Behavior management, a non drug approach, has been effective in reducing signs of agitation. Researchers have yet to compare the effectiveness of drug versus non drug therapy to treat agitation in AD patients and determine which is the best treatment. The Alzheimer's Disease Cooperative Study, with funding from the National Institute on Aging, is conducting an agitation treatment program at 21 sites in 16 States. This study will assess which of the above treatments is most effective.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Masking:
Double
Primary Purpose:
Treatment

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Memory problem consistent with a probable diagnosis of Alzheimer's disease (AD)

    • Agitation symptoms for at least the past 2 weeks

    • Patient has caregiver who can participate

    • Patient lives in the same household as the caregiver

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of California, Los Angeles Los Angeles California United States 90095
    2 University of California, San Diego San Diego California United States 92093-0949
    3 University of Miami Miami Florida United States 33140
    4 University of South Florida Tampa Florida United States 33162
    5 Emory University Atlanta Georgia United States 30329
    6 Southern Illinois University Springfield Illinois United States 62702
    7 University of Kansas Medical Center Kansas City Kansas United States 66160
    8 University of Kentucky Lexington Kentucky United States 40536
    9 University of Massachusetts Worcester Massachusetts United States 01665
    10 University of Michigan Ann Arbor Michigan United States 48109
    11 University of Minnesota Minneapolis Minnesota United States 55455
    12 New York University Medical Center New York New York United States 10016
    13 Mount Sinai Medical Center New York New York United States 10029
    14 University of Rochester Rochester New York United States 14620
    15 University Hospitals of Cleveland Cleveland Ohio United States 44120
    16 Oregon Health Sciences University Portland Oregon United States 97201-3098

    Sponsors and Collaborators

    • National Institute on Aging (NIA)

    Investigators

    • Principal Investigator: Leon Thal, MD., University of California, San Diego

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00000179
    Other Study ID Numbers:
    • IA0003
    • 3U01AG010483-08S2
    First Posted:
    Nov 1, 1999
    Last Update Posted:
    Jun 24, 2005
    Last Verified:
    Mar 1, 2005

    Study Results

    No Results Posted as of Jun 24, 2005